High-intensity Interval Training in Patients With Fibromyalgia
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03924960 |
|
Recruitment Status :
Completed
First Posted : April 23, 2019
Last Update Posted : March 17, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Fibromyalgia | Behavioral: High-intensity interval training Behavioral: Moderate-intensity continuous training Behavioral: Control | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 55 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Single (Investigator) |
| Primary Purpose: | Treatment |
| Official Title: | Effectiveness of High-intensity Interval Training Combined With Resistance Training in Patients With Fibromyalgia |
| Actual Study Start Date : | April 22, 2019 |
| Actual Primary Completion Date : | February 17, 2020 |
| Actual Study Completion Date : | February 17, 2020 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: High-intensity interval training
Participants in this group will perform a 20-25 minutes of aerobic exercise with a maximum capacity of 3-4 minutes (HRmax 80-95%) and active recovery for 3-4 minutes (HRmax 30-50%), five exercise sessions per week for 6 weeks.
|
Behavioral: High-intensity interval training
Participants in this group will perform a 20-25 minutes of aerobic exercise with a maximum capacity of 3-4 minutes (HRmax 80-95%) and active recovery for 3-4 minutes (HRmax 30-50%), five exercise sessions per week for 6 weeks. |
|
Active Comparator: Moderate-intensity continuous training
Participants in this group will perform a 30-45 minute ergometric cycling exercise at 65-70% of the measured maximum heart rate (HRmax), five exercise sessions per week for 6 weeks.
|
Behavioral: Moderate-intensity continuous training
Participants in this group will perform a 30-45 minute ergometric cycling exercise at 65-70% of the measured maximum heart rate (HRmax), five exercise sessions per week for 6 weeks. |
|
Control
Usual care control group
|
Behavioral: Control
Usual care control group |
- Fibromyalgia impact questionnaire [ Time Frame: 6 weeks ]The FIQ was designed to measure the health status of patients with fibromyalgia.
- Visual analogue scale [ Time Frame: 6 weeks ]Pain intensity was measured with visual analogue scale (0-10mm) which is used to measure musculoskeletal pain with very good reliability and validity.
- Short- form health survey 36 [ Time Frame: 6 weeks ]Short- form health survey 36 contains 36 items which are used to evaluate the quality of life of patients with chronic pain. It measures eight different domains that address physical functioning, physical role limitation, pain, general health, vitality, social functioning, emotional role limitation and mental health. The score of each domain ranges from 0 (worse quality of life) to 100 (best quality of life).
- Cardiorespiratory fitness [ Time Frame: 6 weeks ]A symptom-limited maximal cardiopulmonary exercise test performed on a cycle ergometer at baseline and following six-week exercise intervention to measure maximal oxygen consumption (VO2maximum) (ml/ kg/min).
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 65 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | Female |
| Gender Based Eligibility: | Yes |
| Gender Eligibility Description: | female sex |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Subjects diagnosed according to the American College of Rheumatology 2016 diagnostic criteria for fibromyalgia.
Exclusion Criteria:
- History of comorbid inflammatory rheumatic/ connective tissue diseases
- History of cardiovascular or musculoskeletal problems that could prevent them to participate in an exercise program.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03924960
| Turkey | |
| Tuğba Atan | |
| Corum, Turkey, 19100 | |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Tuğba Atan, Assoc. Prof., Hitit University |
| ClinicalTrials.gov Identifier: | NCT03924960 |
| Other Study ID Numbers: |
19-KAEK-023 |
| First Posted: | April 23, 2019 Key Record Dates |
| Last Update Posted: | March 17, 2020 |
| Last Verified: | March 2020 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
fibromyalgia functional capacity aerobic exercise |
|
Fibromyalgia Myofascial Pain Syndromes Muscular Diseases Musculoskeletal Diseases |
Rheumatic Diseases Neuromuscular Diseases Nervous System Diseases |

